Literature DB >> 17041689

Myocardial injury in coronary artery bypass grafting: On-pump versus off-pump comparison by measuring heart-type fatty-acid-binding protein release.

Vishwas Malik1, Shailaja C Kale, Ujjwal K Chowdhury, Lakshmy Ramakrishnan, Sandeep Chauhan, Usha Kiran.   

Abstract

This prospective study uses heart-type fatty-acid-binding protein (hFABP) and creatine kinase-MB (CK-MB) release to compare myocardial injury in on-pump versus off-pump coronary artery bypass grafting (CABG). Fifty patients were randomly assigned to on-pump or off-pump CABG. The hFABP and CK-MB concentrations were measured in serial venous blood samples drawn before heparinization in both groups and after aortic unclamping at 1, 2, 4, 8, 24, 48, and 72 hours in the on-pump group. In the off-pump group, samples were taken after the last distal anastomosis at the same time intervals as in the on-pump group. The total amount of hFABP and CK-MB released was significantly higher in the on-pump than in the off-pump group (hFABP = 100.43 +/- 77.63 vs 3.94 +/- 0.36 ng/mL, P < 0.0001; CK-MB = 33.33 +/- 3.81 vs 28.65 +/- 3.91 log units, P < 0.001). In all patients, hFABP levels peaked as early as 1 hour after declamping (on-pump group) or 2 hours after the last distal anastomosis (off-pump group), whereas CK-MB peaked only at 4 hours after declamping (on-pump group) or 24 hours after the last distal anastomosis (off-pump group). The lower release of hFABP and CK-MB in the off-pump CABG group indicates that on-pump CABG with cardioplegic arrest causes more myocardial damage than does off-pump CABG. Heart-type fatty-acid-binding protein is a more rapid marker of perioperative myocardial damage, peaks earlier than CK-MB, and may predict the requirement for intensive monitoring for postoperative myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041689      PMCID: PMC1592275     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  18 in total

1.  Troponin levels in patients with myocardial infarction after coronary artery bypass grafting.

Authors:  M Carrier; M Pellerin; L P Perrault; B C Solymoss; L C Pelletier
Journal:  Ann Thorac Surg       Date:  2000-02       Impact factor: 4.330

Review 2.  Off-pump coronary artery bypass grafting: not a flash in the pan.

Authors:  Raimondo Ascione; Massimo Caputo; Gianni D Angelini
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

3.  Beating versus arrested heart coronary revascularization: evaluation by cardiac troponin I release.

Authors:  Kifah Alwan; Pierre-Emmanuel Falcoz; Jihad Alwan; Walid Mouawad; Georges Oujaimi; Sidney Chocron; Joseph-Philippe Etievent
Journal:  Ann Thorac Surg       Date:  2004-06       Impact factor: 4.330

4.  Clinical application of markers of cardiac injury: basic concepts and new considerations.

Authors:  J E Adams
Journal:  Clin Chim Acta       Date:  1999-06-30       Impact factor: 3.786

5.  Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting.

Authors:  T Petzold; P Feindt; U Sunderdiek; U Boeken; Y Fischer; E Gams
Journal:  Eur J Cardiothorac Surg       Date:  2001-06       Impact factor: 4.191

6.  Direct myocardial revascularization without extracorporeal circulation. Experience in 700 patients.

Authors:  F J Benetti; G Naselli; M Wood; L Geffner
Journal:  Chest       Date:  1991-08       Impact factor: 9.410

7.  Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery.

Authors:  Tomomi Hasegawa; Naoki Yoshimura; Shigeteru Oka; Yoshio Ootaki; Yoshiya Toyoda; Masahiro Yamaguchi
Journal:  J Thorac Cardiovasc Surg       Date:  2004-06       Impact factor: 5.209

8.  Cardiac troponin I. A marker with high specificity for cardiac injury.

Authors:  J E Adams; G S Bodor; V G Dávila-Román; J A Delmez; F S Apple; J H Ladenson; A S Jaffe
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

9.  A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery.

Authors:  Natasha E Khan; Anthony De Souza; Rebecca Mister; Marcus Flather; Jonathan Clague; Simon Davies; Peter Collins; Duolao Wang; Ulrich Sigwart; John Pepper
Journal:  N Engl J Med       Date:  2004-01-01       Impact factor: 91.245

10.  Coronary artery bypass without cardiopulmonary bypass.

Authors:  A J Pfister; M S Zaki; J M Garcia; L A Mispireta; P J Corso; A G Qazi; S W Boyce; T R Coughlin; P Gurny
Journal:  Ann Thorac Surg       Date:  1992-12       Impact factor: 4.330

View more
  11 in total

1.  Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery.

Authors:  Jochen D Muehlschlegel; Tjörvi E Perry; Kuang-Yu Liu; Amanda A Fox; Charles D Collard; Stanton K Shernan; Simon C Body
Journal:  Anesth Analg       Date:  2010-05-10       Impact factor: 5.108

2.  Comparison of Warm Blood Cardioplegia Delivery With or Without the Use of a Roller Pump.

Authors:  Mizja M Faber; Peter G Noordzij; Simon Hennink; Hans Kelder; Roel de Vroege; Frans G Waanders; Edgar Daeter; Marco C Stehouwer
Journal:  J Extra Corpor Technol       Date:  2015-12

Review 3.  Diagnostic dilemma of perioperative myocardial infarction after coronary artery bypass grafting: A review.

Authors:  Viola Weidenmann; N Bryce Robinson; Lisa Q Rong; Irbaz Hameed; Ajita Naik; Mahmoud Morsi; Philippe Grieshaber; Andreas Böning; Leonard N Girardi; Mario Gaudino
Journal:  Int J Surg       Date:  2020-05-19       Impact factor: 6.071

4.  Perioperative heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery.

Authors:  Florian Rader; Akshat C Pujara; Gregory Pattakos; Jeevanantham Rajeswaran; Liang Li; Laurie Castel; Mina K Chung; A Marc Gillinov; Otto Costantini; David R Van Wagoner; Eugene H Blackstone
Journal:  Heart Rhythm       Date:  2012-10-05       Impact factor: 6.343

5.  Short-term prognostic value of perioperative coronary sinus-derived-serum cardiac troponin-I, creatine kinase-MB, lactate, pyruvate, and lactate-pyruvate ratio in adult patients undergoing open heart surgery.

Authors:  Ujjwal Kumar Chowdhury; Avneesh Sheil; Poonam Malhotra Kapoor; Rajiv Narang; Parag Gharde; Vishwas Malik; Mani Kalaivani; Arindam Chaudhury
Journal:  Ann Card Anaesth       Date:  2016 Jul-Sep

6.  Comparisons of heart-type fatty acid-binding protein (H-FABP) levels in off-pump versus on-pump coronary artery bypass grafting.

Authors:  Mustafa Ozer Ulukan; Murat Ugurlucan; Orcun Unal; Muhammet Fatih Yılmaz; Nilgun Kasifoglu; M Behcet Sevin
Journal:  Arch Med Sci Atheroscler Dis       Date:  2019-05-28

Review 7.  Impact of Cardiopulmonary Bypass Time on Postoperative Duration of Mechanical Ventilation in Patients Undergoing Cardiovascular Surgeries: A Systemic Review and Regression of Metadata.

Authors:  Rashid Nadeem; Shubham Agarwal; Shafaq Jawed; Ammar Yasser; Kamaleldin Altahmody
Journal:  Cureus       Date:  2019-11-06

8.  Plasma kynurenic acid concentration in patients undergoing cardiac surgery: effect of anaesthesia.

Authors:  Edyta Kotlinska-Hasiec; Patrycja Nowicka-Stazka; Jolanta Parada-Turska; Krzysztof Stazka; Janusz Stazka; Przemyslaw Zadora; Wojciech Dabrowski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-09-10       Impact factor: 4.291

9.  High-sensitivity cardiac troponin T is more helpful in detecting peri-operative myocardial injury and apoptosis during coronary artery bypass graft surgery.

Authors:  Emel Fatma Kocak; Cengiz Kocak; Ahmet Aksoy; Ozden Ozben Isiklar; Raziye Akcilar; Ibrahim Fevzi Ozdomanic; Cevher Unsal; Merve Celenk; Irfan Altuntas
Journal:  Cardiovasc J Afr       Date:  2015-07-14       Impact factor: 1.167

10.  Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein

Authors:  Mehmet Kirişci; Aydemir Koçarslan; Duygun Altintaş Aykan; Filiz Alkan Baylan; Adem Doğaner; Yavuz Orak
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.